InVivo Therapeutics Holdings - 8 Year Stock Price History | NVIV

Historical daily share price chart and data for InVivo Therapeutics Holdings since 2010 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for InVivo Therapeutics Holdings as of October 22, 2018 is 2.45.
InVivo Therapeutics Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 7.5317 22.7500 22.7500 1.6900 2.4500 -87.27%
2017 62.9060 103.7500 123.7500 19.0000 19.2500 -81.67%
2016 146.4831 181.7500 246.2500 91.5000 105.0000 -41.67%
2015 270.6587 130.0000 444.5000 130.0000 180.0000 36.36%
2014 134.3373 224.0000 260.0000 50.0000 132.0000 -42.61%
2013 263.1389 175.0000 567.0000 110.0000 230.0000 32.18%
2012 212.9680 279.0000 284.0000 128.0000 174.0000 -36.73%
2011 120.9246 196.0000 310.0000 60.0000 275.0000 22.22%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.019B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.435B 19.38
Abbott Laboratories (ABT) United States $120.206B 24.38
Stryker (SYK) United States $62.741B 24.24
Boston Scientific (BSX) United States $50.643B 26.34
Baxter (BAX) United States $36.875B 25.10
Zimmer Biomet Holdings (ZBH) United States $25.257B 16.23
ResMed (RMD) United States $14.644B 29.07
Smith & Nephew SNATS (SNN) United Kingdom $14.612B 0.00
Perrigo (PRGO) Ireland $9.748B 13.83
Canopy Growth (CGC) Canada $9.572B 0.00
Bio-Rad Laboratories (BIO) United States $8.308B 53.35
Hill-Rom Holdings (HRC) United States $5.726B 19.42
Haemonetics (HAE) United States $5.555B 50.69
ICU Medical (ICUI) United States $5.444B 36.89
Insulet (PODD) United States $5.198B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.212B 0.00
Hutchison China MediTech (HCM) China $3.983B 0.00
Agios Pharmaceuticals (AGIO) United States $3.643B 0.00
Neogen (NEOG) United States $3.276B 49.61
NuVasive (NUVA) United States $3.270B 31.02
National Vision Holdings (EYE) United States $3.195B 70.55
Quidel (QDEL) United States $2.516B 51.55
NxStage Medical (NXTM) United States $1.836B 0.00
Phibro Animal Health (PAHC) United States $1.796B 25.58
Cardiovascular Systems (CSII) United States $1.258B 724.80
AtriCure (ATRC) United States $1.059B 0.00
VAREX IMAGING (VREX) United States $0.987B 16.12
Owens & Minor (OMI) United States $0.914B 9.77
OraSure Technologies (OSUR) United States $0.909B 59.44
Cerus (CERS) United States $0.879B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.875B 25.83
PetIQ (PETQ) United States $0.860B 28.12
Surmodics (SRDX) United States $0.853B 103.08
MacroGenics (MGNX) United States $0.766B 0.00
Omeros (OMER) United States $0.749B 0.00
Meridian Bioscience (VIVO) United States $0.661B 22.59
Insys Therapeutics (INSY) United States $0.607B 0.00
LeMaitre Vascular (LMAT) United States $0.542B 26.98
Lantheus Holdings (LNTH) United States $0.510B 15.85
NanoString Technologies (NSTG) United States $0.452B 0.00
TG Therapeutics (TGTX) United States $0.423B 0.00
Quanterix (QTRX) United States $0.405B 0.00
Evolus (EOLS) United States $0.359B 0.00
Cytosorbents (CTSO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.322B 20.76
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.295B 0.00
Surface Oncology (SURF) United States $0.230B 0.00
Rockwell Medical (RMTI) United States $0.221B 0.00
BioLife Solutions (BLFS) United States $0.209B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Bovie Medical (BVX) United States $0.168B 0.00
Fonar (FONR) United States $0.146B 7.21
Chembio Diagnostics (CEMI) United States $0.140B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
United-Guardian (UG) United States $0.079B 17.33
Imprimis Pharmaceuticals (IMMY) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.073B 0.00
Female Health (VERU) United States $0.073B 0.00
InfuSystems Holdings (INFU) United States $0.062B 0.00
Trinity Biotech (TRIB) Ireland $0.061B 18.19
Neurotrope (NTRP) United States $0.055B 0.00
CAS Medical Systems (CASM) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Capricor Therapeutics (CAPR) United States $0.026B 0.00
Myomo (MYO) United States $0.022B 0.00
Senestech (SNES) United States $0.022B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00